Evolent Health, Inc. EVH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 51.27% | 46.86% | 2.60% | -27.50% | -22.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.27% | 46.86% | 2.60% | -27.50% | -22.83% |
| Cost of Revenue | 67.72% | 66.21% | 8.21% | -34.93% | -29.77% |
| Gross Profit | -11.38% | -19.47% | -18.25% | 28.45% | 23.65% |
| SG&A Expenses | -8.65% | -8.64% | -5.65% | 31.65% | 19.26% |
| Depreciation & Amortization | -8.99% | -6.81% | -10.40% | 485.20% | -20.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.90% | 49.77% | 5.07% | -23.53% | -24.43% |
| Operating Income | -410.03% | -408.46% | -689.02% | -145.84% | 105.34% |
| Income Before Tax | -12.48% | -23.78% | 59.27% | -1,700.81% | 15.99% |
| Income Tax Expenses | 23.40% | 429.09% | -38.10% | -49.60% | 246.37% |
| Earnings from Continuing Operations | -12.95% | -42.55% | 58.79% | -1,781.99% | 9.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.95% | -42.55% | 58.79% | -1,781.99% | 9.82% |
| EBIT | -410.03% | -408.46% | -689.02% | -145.84% | 105.34% |
| EBITDA | -26.88% | -65.39% | -71.16% | 32.42% | 68.45% |
| EPS Basic | 11.73% | 42.84% | 62.01% | -1,344.87% | 13.17% |
| Normalized Basic EPS | -26.34% | -230.46% | 56.46% | -285.81% | 25.70% |
| EPS Diluted | 11.73% | 42.84% | 62.01% | -1,344.87% | 13.17% |
| Normalized Diluted EPS | -26.34% | -230.46% | 56.46% | -285.81% | 25.70% |
| Average Basic Shares Outstanding | -0.87% | -2.88% | -2.96% | -2.97% | -0.69% |
| Average Diluted Shares Outstanding | -0.87% | -2.88% | -2.96% | -2.97% | -0.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 1.00% | 0.58% |